TrialCell reports2014
Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors.
Filip Janku et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
146 papers cite itlatest 60 shown
this paperpooled ittrialcites it